Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder.

Third, although the sample size was small, CB1R immunoreactivity levels showed a trend to being higher in area 46 from monkeys after long-term exposure to haloperidol at doses that mimicked the therapeutic treatment of schizophrenia ( Figure 6 ).

also in 53,322 other papers